June 7, 2021

Adverse Events Following MRNA SARS-CoV-2 Vaccination among U.S. Nursing Home Residents

Category: Article Summary

Topic: Vaccines and Immunity

Keywords (Tags): adverse events, vaccine

• No major safety problems were detected following the first or second dose of either of the two mRNA SARS-CoV-2 vaccines in a study of electronic health records from US nursing home residents (n = 8,553) between December 18, 2020 and March 7, 2021. The analysis of pre-specified adverse events did not detect statistical signals for any pre-specified outcomes, including anaphylaxis, seizures, Guillain-Barre Syndrome, or myocarditis.

Bardenheier et al. (May 2021). Adverse Events Following MRNA SARS-CoV-2 Vaccination among U.S. Nursing Home Residents. Vaccine. https://doi.org/10.1016/j.vaccine.2021.05.088